SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-112719
Filing Date
2019-04-22
Accepted
2019-04-22 06:07:03
Documents
5
Period of Report
2019-06-11
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d727791ddef14a.htm DEF 14A 581029
2 GRAPHIC g727791g67c71.jpg GRAPHIC 8721
3 GRAPHIC g727791g97s65.jpg GRAPHIC 57988
4 GRAPHIC g727791n1.jpg GRAPHIC 162048
5 GRAPHIC g727791n2.jpg GRAPHIC 175227
  Complete submission text file 0001193125-19-112719.txt   1138862
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36276 | Film No.: 19758589
SIC: 2834 Pharmaceutical Preparations